Acute small-bowel toxicity during neoadjuvant combined radiochemotherapy in locally advanced rectal cancer: determination of optimal dose-volume cut-off value predicting grade 2–3 diarrhoea

BACKGROUND: Current therapeutic standard for locally advanced rectal cancer is the neoadjuvant radiochemotherapy with total mesorectal excision. Diarrhoea is the main acute side effect, induced by the dose to the small-bowel, frequently leading to a treatment modification. Aim of this study was to a...

Descripción completa

Detalles Bibliográficos
Autores principales: Reis, Tina, Khazzaka, Edwin, Welzel, Grit, Wenz, Frederik, Hofheinz, Ralf–Dieter, Mai, Sabine
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2015
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4324657/
https://www.ncbi.nlm.nih.gov/pubmed/25636703
http://dx.doi.org/10.1186/s13014-015-0336-5

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4324657/
https://www.ncbi.nlm.nih.gov/pubmed/25636703
http://dx.doi.org/10.1186/s13014-015-0336-5

Ejemplares similares